化学
雌激素受体
噻吩
体外
受体
呋喃
选择性
配体结合分析
雌激素
选择性雌激素受体调节剂
立体化学
对接(动物)
竞争性约束
效力
荧光素酶
报告基因
组合化学
生物化学
转染
基因
基因表达
内科学
有机化学
医学
护理部
癌症
乳腺癌
催化作用
作者
José Juan Rodríguez,Kamila Filipiak,Maciej Masłyk,Jakub Ciepielski,Sebastian Demkowicz,Sonia de Pascual‐Teresa,Sonsoles Martín‐Santamaría,Beatriz de Pascual‐Teresa,Ana Ramos
摘要
Based on the benzo[b]naphtho[1,2-d]furan and benzo[b]naphtho[1,2-d]thiophene frameworks, a series of ligands with different basic side chains (BSCs) has been synthesized and pharmacologically evaluated. Also, their binding modes have been modelled using docking techniques. It was found that the introduction of a BSC in these systems brings about a decrease of affinity for both estrogen receptors α and β in an in vitro competitive binding assay. However, two full antagonists of the estrogen receptor β (9c and 9f) have been discovered, with potency in the low micromolar concentration in a cell-based luciferase reporter assay, and completely devoid of activity against the α receptor at the same concentration range. Differences in the ERα/ERβ binding modes have also been rationalized with the help of molecular modelling techniques. This interesting functional profile could be used to elucidate the physiological role of each ER subtype.
科研通智能强力驱动
Strongly Powered by AbleSci AI